Member Info for Leggster

No bad news in the RNS but lots to be positive on in the comings weeks and months, lots of disruptor comments here, I respect your views but you are clearly traders rather than investors. We are at the cusp of the published strategy for SAR, a few weeks/months will leave a clearer position, trading at this time for me as an investor would be madness, win or lose holding and waiting for the outcome is my strategy. DYOR GLA

Damion, really interesting I joined this investor meet and do not recall this answer but really insightful, thank you for sharing this segment. GLA

Great RNS very e couraged by the statement below around parallel activity

'The safety committee will also establish the maximum dose to move forward into cohort A of Part 2, based on the safety and pharmacokinetic data observed to date in Part 1 (single ascending dose stage). Part 2 will begin in parallel with additional planned dose escalation in Part 1 of the study.'

GLA

Lots of attempts to paint the negative, but look rationally at the situation, 737 can deliver a deal but its complex in Combo and is taking time, this created a short term cashflow need thus RF deal, 1801 is 10 weeks in and recruiting for the next phase of the trial with no issues, 1802 benefits from the 1801 testing through its similar profile, great patent protection, cash runway allows a stronger negotiating hand, the volume of upside for me offers a chance of high reward, GLA

Those predicting a significant decrease in value paint a single story which could come fruition.

I though view events differently 9 weeks of trial have completed in Australia. I believe the BOD know what current data shows and are fully confident that they will get approval to proceed. They therefore are confident that they will shortly have positive news to report. Concurrently they are discussing deals to take away the chance of being lowballed they wanted funding quickly, they achieve this via Riverfort in full knowledge of how some will try and interprete the transaction but also in full knowledge of the news they will release gapping the SP upwards and allowing RF to sell into the market without damage. IMO opinion the lack of balance from the death spiral adherents is based on a lack of appreciation on where the science and process currently sits.

I'm still fully confidant at this point a temporary dip is my prediction with imminent news approaching of which the board are fully cognizant in this scenario believing in the BOD I think is the right thing to do. GLA

Lots of different motivations surfacing, I do find shorting personally distasteful I feel it lacks in a moral context, however we all have our own strategies. On this occasion despite the disaster path for LTHs being one possible outcome I choose to view this differently. Why would Tim and John engage in an action that destroys the value of their own holdings and future wealth, I do not believe they would IMO they are in negotiation and to strengthen their hand to drive the best deal needed a longer cash runway this facility IMO was just a route to strength their cash position quickly. I choose to believe that Riverfort have chosen to offer the facility because they see a short term profit from a rising sharepoint. I am more confident than ever that we are in negotiations on 1801, we have completed 9 weeks of trials with no issues, 737 negotiations must be nearing an end, news could flow at anytime and the risk continues to reduce. GLA

With Oracle here, nearly at the end of the 9th week, no bad news RNS, a bit of a raise to extend the cash runway, still have 737 to report back, great patent protection, 1801 to be followed by 1802, SKIL platform in hand, doomsters circling trying to make a quick buck. Nothing that I find concerning in the current scenario, it is though a tough waiting period but I am convinced some of today's posters would not be here if we were not getting close to a gap in SP upwards once news drops. GLA

Aber, completely agree this is good news, runway is now secure, shows confidence in the trial, phasing for draw down is sensible as allows a deal to land. The doomsters are out in force this morning which I always take as a positive sign, but I will not be selling. GLA

Also feeling highly confident, I believed the BOD on tox reports and we could see results for other companies on similar molecules. Getting 8 weeks in with no news shows for me that prior assumptions are proving to be true. Some sort of news though would be welcome, preferably an RNS but even a tweet would be nice.... perhaps something like - 'n' weeks into our trial. Exciting to see the continued progression of the trial.....GLA

HBD I enjoyed your post personally part of the fun of investing is creating your strategy based around what you believe maybe the sequence of events and debating these interpretations of events is the fun of these BB's. If people only posted when there is an RNS then engagement would be very low GLA

Another week over in Australia, no news and importantly no bad news. Time is ticking past and we are going deeper into the trial all the time lots to like here IMO, FOMO will kick in at some point as we get closer to an update. GLA

A blue day would be nice, the days without news continue to build, no news is though good news, but a little update would be great. GLA

If bad news was already known they would have to release immediately. I see this as a last treeshake before good news next week. If I'm wrong though I will live with it, the possible upside is well worth the risk. GLA

HBD this was perhaps then a factor in why they choose psoriasis as the indication to trial against?

Lets be excited then and assume the super happy path, 11.00 then for an RNS? It is a Thursday, one of SARs preferred news days! Difficult not to get excited as the time passes and we see no pauses in the programme. High risk still but fractionally less risky with every passing day. GLA

Lots of debate on the BB in this period of waiting, my thoughts are as follows. Investors in this share know this is a high risk investment, although the BOD often see target dates slip this is not in my opinion a problem, I prefer a delay and full attention to detail rather than short cuts or additional risk to hit a date. We have a returned asset in 737 where I choose to believe the BOD and do expect a deal, on 1801 we are in clinic where I would like to see more regular updates but no news is good news at this time as well, 1802 is moving in the background, and the Skil platform and perhaps even FLT3 have value. Our IP is well protected and our small leadership team are all credible. Volume is low but the price is moving disproportionately, again I'm ignoring this as it is news updates which are going to make the real difference to the SP. IMO we are well positioned to reach the end game we would expect from SARs published strategy and we should for good or ill know where the dice land in the not too distant future. GLA

In my view there is no doubt we have a market of decent size, the science appears sound the due diligence on protecting IP appears robust, success in trials will IMO move the SP, a deal will happen all is good. GLA

I agree if taken down much further I may top up with more, even though I keep telling myself that I am already invested as high as I want to go. GLA exciting days, weeks and months ahead

I would have thought lots of RNS updates to achieve an orderly rise in SP would be appropriate. They must have a motive not to take that opportunity, perhaps something else to announce, let's hope its not a low ball takeover...

Very quiet here on the board this weekend, will we get a trial update this week? Feel one must be incoming as now a decent few weeks into the process. However SAR are always surprising, the patent RNS was welcome and unexpected to me, with what appears at times an odd IR strategy they are rather maverick. GLA